• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于底物的胞质核苷酸酶IIIB抑制剂设计及抑制机制的结构见解

Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.

作者信息

Kubacka Dorota, Kozarski Mateusz, Baranowski Marek R, Wojcik Radoslaw, Panecka-Hofman Joanna, Strzelecka Dominika, Basquin Jerome, Jemielity Jacek, Kowalska Joanna

机构信息

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093 Warsaw, Poland.

Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.

出版信息

Pharmaceuticals (Basel). 2022 Apr 29;15(5):554. doi: 10.3390/ph15050554.

DOI:10.3390/ph15050554
PMID:35631380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9144445/
Abstract

Cytosolic nucleotidases (cNs) catalyze dephosphorylation of nucleoside 5'-monophosphates and thereby contribute to the regulation of nucleotide levels in cells. cNs have also been shown to dephosphorylate several therapeutically relevant nucleotide analogues. cN-IIIB has shown in vitro a distinctive activity towards 7-mehtylguanosine monophosphate (mGMP), which is one key metabolites of mRNA cap. Consequently, it has been proposed that cN-IIIB participates in mRNA cap turnover and prevents undesired accumulation and salvage of mGMP. Here, we sought to develop molecular tools enabling more advanced studies on the cellular role of cN-IIIB. To that end, we performed substrate and inhibitor property profiling using a library of 41 substrate analogs. The most potent hit compounds (identified among mGMP analogs) were used as a starting point for structure-activity relationship studies. As a result, we identified several 7-benzylguanosine 5'-monophosphate (BnGMP) derivatives as potent, unhydrolyzable cN-IIIB inhibitors. The mechanism of inhibition was elucidated using X-ray crystallography and molecular docking. Finally, we showed that compounds that potently inhibit recombinant cN-IIIB have the ability to inhibit mGMP decay in cell lysates.

摘要

胞质核苷酸酶(cNs)催化核苷5'-单磷酸的去磷酸化反应,从而有助于调节细胞内的核苷酸水平。cNs还被证明能够使几种具有治疗意义的核苷酸类似物去磷酸化。cN-IIIB在体外已显示出对7-甲基鸟苷单磷酸(mGMP)具有独特的活性,mGMP是mRNA帽的关键代谢产物之一。因此,有人提出cN-IIIB参与mRNA帽的周转,并防止mGMP的不必要积累和挽救。在这里,我们试图开发分子工具,以便能够更深入地研究cN-IIIB在细胞中的作用。为此,我们使用包含41种底物类似物的文库进行了底物和抑制剂特性分析。最有效的命中化合物(在mGMP类似物中鉴定)被用作构效关系研究的起点。结果,我们鉴定出几种7-苄基鸟苷5'-单磷酸(BnGMP)衍生物作为有效的、不可水解的cN-IIIB抑制剂。使用X射线晶体学和分子对接阐明了抑制机制。最后,我们表明,能有效抑制重组cN-IIIB的化合物具有抑制细胞裂解液中mGMP降解的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/463602f3b505/pharmaceuticals-15-00554-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/d99a26bc50dd/pharmaceuticals-15-00554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/8692a0748cc7/pharmaceuticals-15-00554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/ef2cbebed968/pharmaceuticals-15-00554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/e3bc8f097134/pharmaceuticals-15-00554-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/d4bac6f743cd/pharmaceuticals-15-00554-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/007fab65a36a/pharmaceuticals-15-00554-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/0880a83a83f7/pharmaceuticals-15-00554-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/13f4c207cce7/pharmaceuticals-15-00554-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/463602f3b505/pharmaceuticals-15-00554-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/d99a26bc50dd/pharmaceuticals-15-00554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/8692a0748cc7/pharmaceuticals-15-00554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/ef2cbebed968/pharmaceuticals-15-00554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/e3bc8f097134/pharmaceuticals-15-00554-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/d4bac6f743cd/pharmaceuticals-15-00554-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/007fab65a36a/pharmaceuticals-15-00554-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/0880a83a83f7/pharmaceuticals-15-00554-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/13f4c207cce7/pharmaceuticals-15-00554-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9144445/463602f3b505/pharmaceuticals-15-00554-g009.jpg

相似文献

1
Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.基于底物的胞质核苷酸酶IIIB抑制剂设计及抑制机制的结构见解
Pharmaceuticals (Basel). 2022 Apr 29;15(5):554. doi: 10.3390/ph15050554.
2
Crystal structures of the novel cytosolic 5'-nucleotidase IIIB explain its preference for m7GMP.新型胞质5'-核苷酸酶IIIB的晶体结构解释了其对m7GMP的偏好性。
PLoS One. 2014 Mar 6;9(3):e90915. doi: 10.1371/journal.pone.0090915. eCollection 2014.
3
7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.具有5'-(1,2,3-三唑基)部分的7-甲基鸟苷单磷酸类似物:作为cNIIIB核苷酸酶抑制剂的合成与评价
Bioorg Med Chem. 2018 Jan 1;26(1):191-199. doi: 10.1016/j.bmc.2017.11.032. Epub 2017 Nov 22.
4
Identification of Drosophila and human 7-methyl GMP-specific nucleotidases.鉴定果蝇和人类 7-甲基 GMP 特异性核苷酸酶。
J Biol Chem. 2013 Jan 25;288(4):2441-51. doi: 10.1074/jbc.M112.426700. Epub 2012 Dec 5.
5
Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.胞质 5'-核苷酸酶 II(cN-II)的核核苷酸 5'-单磷酸类似物抑制的结构见解。
PLoS Comput Biol. 2011 Dec;7(12):e1002295. doi: 10.1371/journal.pcbi.1002295. Epub 2011 Dec 8.
6
Recent advances in structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II (cN-II).细胞质 IMP-GMP 特异性 5'-核苷酸酶 II(cN-II)的结构与功能的最新进展。
Purinergic Signal. 2006 Nov;2(4):669-75. doi: 10.1007/s11302-006-9009-z. Epub 2006 Jun 29.
7
Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II.人胞质 5'-核苷酸酶 II 的变构调节和底物识别的结构基础。
J Mol Biol. 2011 May 13;408(4):684-96. doi: 10.1016/j.jmb.2011.02.059. Epub 2011 Mar 17.
8
Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.细胞质 5'-核苷酸酶 II 的酶学性质和生理作用。
Curr Med Chem. 2013;20(34):4260-84. doi: 10.2174/0929867311320340006.
9
Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy.胞质和线粒体脱氧核糖核苷酸酶:与底物类似物、抑制剂的活性及治疗意义
Biochem Pharmacol. 2003 Aug 1;66(3):471-9. doi: 10.1016/s0006-2952(03)00290-9.
10
Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent translation.探索色胺缀合物作为靶向帽依赖性翻译的磷酸化修饰 7-甲基鸟嘌呤核苷酸的前核苷。
Bioorg Med Chem. 2020 Jul 1;28(13):115523. doi: 10.1016/j.bmc.2020.115523. Epub 2020 Apr 25.

引用本文的文献

1
Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine.邻近诱导的硫氟交换反应增强了胞质核苷酸酶抑制剂的效力,并揭示了一个罕见的共价靶向组氨酸的例子。
RSC Chem Biol. 2025 Apr 23. doi: 10.1039/d5cb00005j.
2
A Novel m7G-Related Genes-Based Signature with Prognostic Value and Predictive Ability to Select Patients Responsive to Personalized Treatment Strategies in Bladder Cancer.一种基于新型m7G相关基因的特征,具有预后价值和预测能力,可用于选择对膀胱癌个性化治疗策略有反应的患者。
Cancers (Basel). 2022 Oct 29;14(21):5346. doi: 10.3390/cancers14215346.

本文引用的文献

1
Novel N7-Arylmethyl Substituted Dinucleotide mRNA 5' cap Analogs: Synthesis and Evaluation as Modulators of Translation.新型N7-芳基甲基取代的二核苷酸mRNA 5'帽类似物:作为翻译调节剂的合成与评价
Pharmaceutics. 2021 Nov 16;13(11):1941. doi: 10.3390/pharmaceutics13111941.
2
Prognostic impact of cN-III mRNA expression on overall survival and drug sensitivity in pediatric leukemia.cN-III mRNA表达对小儿白血病总生存期和药物敏感性的预后影响
Leuk Lymphoma. 2022 Feb;63(2):457-462. doi: 10.1080/10428194.2021.1992616. Epub 2021 Oct 18.
3
Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients.
核苷/核苷酸类似物及抗逆转录病毒药物拉米夫定的潜在新用途:改善癌症和新冠肺炎患者的治疗效果
Front Oncol. 2021 Jul 21;11:664794. doi: 10.3389/fonc.2021.664794. eCollection 2021.
4
Evidence for a Cross-Talk Between Cytosolic 5'-Nucleotidases and AMP-Activated Protein Kinase.胞质5'-核苷酸酶与AMP激活的蛋白激酶之间存在相互作用的证据。
Front Pharmacol. 2020 Dec 21;11:609849. doi: 10.3389/fphar.2020.609849. eCollection 2020.
5
Molecular basis of the selective processing of short mRNA substrates by the DcpS mRNA decapping enzyme.DcpS mRNA 脱帽酶对短 mRNA 底物进行选择性加工的分子基础。
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19237-19244. doi: 10.1073/pnas.2009362117. Epub 2020 Jul 28.
6
Deciphering the mechanistic effects of eIF4E phosphorylation on mRNA-cap recognition.解析 eIF4E 磷酸化对 mRNA 帽识别的机制效应。
Protein Sci. 2020 Jun;29(6):1373-1386. doi: 10.1002/pro.3798. Epub 2019 Dec 16.
7
Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data.Coot 在电子冷冻显微镜和晶体学数据的大分子模型构建方面的最新进展。
Protein Sci. 2020 Apr;29(4):1069-1078. doi: 10.1002/pro.3791. Epub 2020 Mar 2.
8
Purine-Metabolising Enzymes and Apoptosis in Cancer.癌症中的嘌呤代谢酶与细胞凋亡
Cancers (Basel). 2019 Sep 12;11(9):1354. doi: 10.3390/cancers11091354.
9
N1-Propargylguanosine Modified mRNA Cap Analogs: Synthesis, Reactivity, and Applications to the Study of Cap-Binding Proteins.N1-丙炔基鸟苷修饰的 mRNA 帽类似物:合成、反应性及在帽结合蛋白研究中的应用。
Molecules. 2019 May 17;24(10):1899. doi: 10.3390/molecules24101899.
10
Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein.真核起始因子 4E(eIF4E):帽子结合蛋白概述。
J Cell Biochem. 2019 Sep;120(9):14201-14212. doi: 10.1002/jcb.28851. Epub 2019 May 9.